Literature DB >> 24287583

Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compound.

Luigi Messori1, Federica Scaletti, Lara Massai, Maria Agostina Cinellu, Irene Russo Krauss, Giovanna di Martino, Alessandro Vergara, Luigi Paduano, Antonello Merlino.   

Abstract

The reaction of Auoxo6, a dinuclear gold(III) complex, with the model protein bovine pancreatic ribonuclease is explored here by X-ray diffraction and ESI mass spectrometry. Data provide clues on the processes of adduct formation and of enzyme inhibition and, inductively, on the likely mode of action of this metallodrug.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24287583     DOI: 10.1039/c3mt00265a

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  4 in total

1.  Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c.).

Authors:  Luigi Messori; Maria Agostina Cinellu; Antonello Merlino
Journal:  ACS Med Chem Lett       Date:  2014-07-31       Impact factor: 4.345

2.  Synthesis, Characterization, and Antiproliferative Activity of Novel Chiral [QuinoxP*AuCl2]+ Complexes.

Authors:  Adedamola S Arojojoye; R Tyler Mertens; Samuel Ofori; Sean R Parkin; Samuel G Awuah
Journal:  Molecules       Date:  2020-12-04       Impact factor: 4.411

3.  Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A.

Authors:  Giarita Ferraro; Nicola Demitri; Luigi Vitale; Giuseppe Sciortino; Daniele Sanna; Valeria Ugone; Eugenio Garribba; Antonello Merlino
Journal:  Inorg Chem       Date:  2021-11-30       Impact factor: 5.165

Review 4.  Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey.

Authors:  Iogann Tolbatov; Alessandro Marrone; Cecilia Coletti; Nazzareno Re
Journal:  Molecules       Date:  2021-12-15       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.